BioSpace News Archive

Business

Robocath Sets Up Medical Advisory Board Composed of International Interventional Cardiology Key Leaders

Robocath announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology.

January 30, 2018
·
2 min read
Deals

Innovate Biopharmaceuticals Announces Successful Merger Completion

Innovate Biopharmaceuticals shares will commence trading on Nasdaq with the new ticker INNT and will reflect the 1 for 10 reverse split in trading on Wednesday, January 31, 2018.

January 30, 2018
·
6 min read
Business

Syapse Expands Precision Medicine to Asia Through Partnerships With Seoul National University Hospital and Megazone

Syapse and SNUH are launching a precision oncology program to improve cancer care in Korea, with the support of Megazone’s innovative cloud services.

January 30, 2018
·
4 min read
Business

Edico Genome Bolsters Sales and Business Development Leadership

Edico Genome today announced the expansion of its commercial leadership team with the appointment of Mike Harkins as vice president of sales and Katherine Atkinson as vice president of business development.

January 30, 2018
·
3 min read
FIRE1 Raises $50M Series C

The financing provides FIRE1 with capital to further advance its novel remote monitoring solution to improve outcomes for heart failure patients.

January 30, 2018
·
6 min read
Auris Medical Announces Pricing of $5.5M Registered Direct Offering

The Company also agreed to issue warrants to purchase up to an aggregate of 7,499,999 common shares to the investors in a concurrent private placement.

January 30, 2018
·
4 min read
Deals

Eyenovia Announces Closing of $27.3M Initial Public Offering

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services and Roth Capital Partners acted as joint book-running managers for the offering.

January 30, 2018
·
2 min read
Biotech Bay

Five Prime Therapeutics Announces Closing of Upsized Public Offering

Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Leerink Partners LLC are acting as book-running managers for the offering.

January 30, 2018
·
1 min read
Business

Amarin Announces Proposed Public Offering of American Depositary Shares

On January 26, 2018, the last sale price of the ADSs on The NASDAQ Global Market was $4.27 per share.

January 30, 2018
·
4 min read
Genetown

Albireo Announces Closing of $74.8M Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares

Cowen and William Blair acted as joint book-running managers and representatives of the underwriters for the offering.

January 30, 2018
·
2 min read